Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:acquiredBy |
gptkb:Cadence_Pharmaceuticals
gptkb:Questcor_Pharmaceuticals Ikaria Inc. |
| gptkbp:CEO |
gptkb:Siggi_Olafsson
|
| gptkbp:country |
gptkb:United_Kingdom
|
| gptkbp:filedForBankruptcy |
2020
2023 |
| gptkbp:foundedYear |
1867
|
| gptkbp:fullName |
gptkb:Mallinckrodt_Pharmaceuticals
|
| gptkbp:headquartersLocation |
gptkb:Staines-upon-Thames,_United_Kingdom
|
| https://www.w3.org/2000/01/rdf-schema#label |
MNK
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:legalIssue |
opioid litigation
|
| gptkbp:listedOn |
gptkb:NYSE
|
| gptkbp:notableProduct |
gptkb:Acthar_Gel
gptkb:INOMAX gptkb:Ofirmev Therakos |
| gptkbp:numberOfEmployees |
~3,400 (2023)
|
| gptkbp:previouslyHeadquarteredIn |
gptkb:St._Louis,_Missouri,_United_States
|
| gptkbp:products |
generic drugs
specialty pharmaceuticals imaging agents |
| gptkbp:stockSymbol |
gptkb:MNK
|
| gptkbp:bfsParent |
gptkb:Macon-Fower_Memorial_Airport
|
| gptkbp:bfsLayer |
7
|